Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Underperformed after lowering its Vault CRM adoption target from 16 to 14 of the top 20 global pharmaceutical companies, causing concerns over competitive traction from Salesforce's Life Sciences Cloud.
— Scott O'Gorman, Andy Colyer, Daniel White
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Veeva Systems, Inc.
Veeva Systems, Inc (VEEV) was the largest contributor to Portfolio performance during the quarter. The company develops...
Veeva Systems Inc. ($VEEV) develops specialized cloud-based software solutions, clinical data suites, and customer relationship management (CRM) platforms specifically tailored for the global life sciences and pharmaceutical industry. The investment manager...
Veeva provides specialised cloud-based software designed specifically for the pharmaceutical and life sciences industries.